For the collection and testing of human blood and human plasma, Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC [OJ L 33, 8.2.2003, p. 30.] shall apply.
Art. 109 Directive (EU) 2001/83
Directive (EU) 2002/9831Lawamends
Член 109 от Директива 2001/83/ЕО се заменя със следния текст: За вземането и диагностиката на човешка кръв и човешка кръвна плазма се …
Judgment of the Court (First Chamber), 13 March 2014. Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de Decisioninterprets
Accordingly, as the Advocate General noted at point 26 of his Opinion, Article 109 of Directive 2001/83, as amended by Directive 2002/98, provides that Directive 2002/98 applies to the collection and testing of human blood and human …
13 Mar 2014 · 62012CJ0512
… L'articolo 109 della direttiva 2001/83/CE è stato modificato. I medicinali derivati dal plasma sono, per loro natura, medicinali biologici la cui fabbricazione si basa su un accurato trattamento del plasma umano come materia prima. Per …
Judgment of the Court (Third Chamber) of 8 June 2017. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision
In Title X of Directive 2001/83, which concerns specific provisions on medicinal products derived from human blood and human plasma, Article 109 provides: ‘For the collection and testing of human blood and human plasma, Directive …
8 Jun 2017 · 62015CJ0296
Opinion of Advocate General Saugmandsgaard Øe delivered on 1 December 2016. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision
As the Court explained in the judgment in Octapharma France, [Judgment of 13 March 2014, Octapharma France (C‑512/12, EU:C:2014:149, paragraph 40): ‘plasma from whole blood which is prepared by a method involving an industrial process …
1 Dec 2016 · 62015CC0296
Opinion of Advocate General Jääskinen delivered on 7 November 2013. Octapharma France SAS v Agence nationale de sécurité du médicament et deDecision
In consequence, Article 31 of Directive 2002/98 replaced the text of Article 109 of Directive 2001/83 with the following: ‘Article 109 For the collection and testing of human blood and human plasma, Directive 2002/98/EC of the European …
7 Nov 2013 · 62012CC0512
Conseil d'État, 1ère / 6ème SSR, 23/07/2014, 349717, Publié au recueil LebonDecision
… humaine, à l'exception du plasma dans la production duquel intervient un processus industriel " ; qu'aux termes de l'article 109 de la directive 2001/83/CE, telle que modifiée par la directive 2002/98/CE du 27 janvier 2003 : " Pour ce …
23 Jul 2014 · CETATEXT000029288207
- num:eu=2002/98 (several documents carry this name)
Changed on 26 Jan 2007
For the collection and testing of human blood and human plasma, Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (1 ) [OJ L 33, 8.2.2003, p. 30.] shall apply.
- 26 Jan 2007 – todayin force
- 8 Feb 2003 – 26 Jan 2007earlier wording
- 6 Nov 2001 – 8 Feb 2003earlier wording
Versions are held from 6 Nov 2001; the article may be older.